The cash flow of ELI LILLY AND COMPANY over the past 10 years
Chart ELI LILLY AND COMPANY: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ELI LILLY AND COMPANY's operating cash flow was $16.81B and its capital expenditures $7.84B, leaving free cash flow of $8.97B. Free cash flow was above zero in all 10 years shown. It ranged from $792M in fiscal 2023 to $8.97B in fiscal 2025. Capital expenditures were highest in fiscal 2025, at $7.84B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $16.81B | $7.84B | $8.97B |
| 2024ended Dec 31, 2024 | $8.82B | $5.06B | $3.76B |
| 2023ended Dec 31, 2023 | $4.24B | $3.45B | $792M |
| 2022ended Dec 31, 2022 | $7.59B | $1.85B | $5.73B |
| 2021ended Dec 31, 2021 | $7.37B | $1.31B | $6.06B |
| 2020ended Dec 31, 2020 | $6.5B | $1.39B | $5.11B |
| 2019ended Dec 31, 2019 | $4.84B | $1.03B | $3.8B |
| 2018ended Dec 31, 2018 | $5.52B | $1.21B | $4.31B |
| 2017ended Dec 31, 2017 | $5.62B | $1.08B | $4.54B |
| 2016ended Dec 31, 2016 | $4.85B | $1.04B | $3.81B |
Fiscal years as ELI LILLY AND COMPANY reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ELI LILLY AND COMPANY
- The revenue of ELI LILLY AND COMPANY
- The profitability of ELI LILLY AND COMPANY
- The debt of ELI LILLY AND COMPANY
- The dividends of ELI LILLY AND COMPANY
- All of ELI LILLY AND COMPANY's financials, charted
Companies of a similar size
- AKTXAkari Therapeutics, Plc
- MUMicron Technology, Inc.
- TSLATesla, Inc.
- TBLATABOOLA.COM LTD.
- AVGOBroadcom Inc.
Not investment advice. This page shows what ELI LILLY AND COMPANY filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.